Skip to main content
Log in

Short-Course Systemic and Topical Non-Steroidal Anti-Inflammatory Drugs: Impact on Adverse Renal Events in Older Adults with Co-Morbid Disease

  • Original Research Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Background

Prolonged systemic non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with adverse renal outcomes among older adults. However, there is scant data regarding the renal safety of topical and short-course systemic NSAIDs. We aimed to evaluate the risk of acute adverse renal outcomes among older adults prescribed topical and short-term systemic NSAIDs.

Methods

We conducted a retrospective cohort study of all older adults, age 60 years and above, who received prescriptions between July 2015 and December 2017 from the largest tertiary hospital and a major public primary care institution in Singapore. Data from 6 months before until 30 days after the first prescription were retrieved from electronic medical records. The primary outcome was the incidence of acute kidney injury (serum creatinine increased >26.5 µmol/L or >50% from baseline) and/or hyperkalemia within 30 days. A multi-variate analysis taking into account age, sex, co-morbidities, baseline-estimated glomerular filtration rate and serum potassium, NSAID route of administration, and concurrent renin-angiotensin-aldosterone system blocker and diuretic prescription was performed to evaluate factors associated with the primary outcome.

Results

We identified 12,773 older adults with incident prescriptions: 3982 (31.2%) received short-course systemic NSAIDs, 3784 (29.6%) received topical NSAIDs, and 5007 (39.2%) did not receive any NSAID. Both short-course systemic NSAIDs (adjusted odds ratio [OR] 1.59, 95% confidence interval [CI] 1.41–1.80, p < 0.001) and topical NSAIDs (adjusted OR 1.48, 95% CI 1.31–1.67, p < 0.001), compared with the no-NSAID group, were independently associated with the primary outcome. Among older adults with co-morbid conditions and prescribed NSAIDs, topical NSAIDs had a reduced odds of 30-day incident acute kidney injury and/or hyperkalemia in diabetes mellitus (adjusted OR 0.78, 95% CI 0.65–1.06, p = 0.007), chronic kidney disease (adjusted OR 0.74, 95% CI 0.60–0.90, p = 0.003), and cardiovascular disease (adjusted OR 0.54, 95% CI 0.37–0.79, p < 0.001), compared with short-course systemic NSAIDs.

Conclusions

NSAIDs increased the risk of acute adverse renal events. Topical NSAIDs, compared with short-course systemic NSAIDs, were associated with a reduced incidence of acute kidney injury and/or hyperkalemia among older adults with additional risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Zhang X, Donnan PT, Bell S, Guthrie B. Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol. 2017;18(1):256.

    Article  Google Scholar 

  2. Nash DM, Markle-Reid M, Brimble KS, McArthur E, Roshanov PS, Fink JC, et al. Nonsteroidal anti-inflammatory drug use and risk of acute kidney injury and hyperkalemia in older adults: a population-based study. Nephrol Dial Transplant. 2019;4(7):1145–54.

    Article  Google Scholar 

  3. 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94.

    Article  Google Scholar 

  4. Szeto C-C, Sugano K, Wang J-G, Fujimoto K, Whittle S, Modi GK, et al. Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations. Gut. 2020;69(4):617–29.

    Article  CAS  Google Scholar 

  5. Juhlin T, Björkman S, Höglund P. Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE-inhibitors. Eur J Heart Fail. 2005;7(6):1049–56.

    Article  CAS  Google Scholar 

  6. Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med. 2000;160(6):777–84.

    Article  CAS  Google Scholar 

  7. Bally M, Beauchamp ME, Abrahamowicz M, Nadeau L, Brophy JM. Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposure. Pharmacoepidemiol Drug Saf. 2018;27(1):69–77.

    Article  CAS  Google Scholar 

  8. Altman RD. New guidelines for topical NSAIDs in the osteoarthritis treatment paradigm. Curr Med Res Opin. 2010;26(12):2871–6.

    Article  CAS  Google Scholar 

  9. Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases. Drugs. 2000;60(3):555–74.

    Article  CAS  Google Scholar 

  10. Zeng C, Wei J, Persson MS, Sarmanova A, Doherty M, Xie D, et al. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies. Br J Sports Med. 2018;52(10):642–50.

    Article  Google Scholar 

  11. Fernando AH, Thomas S, Temple RM, Lee HA. Renal failure after topical use of NSAIDs. BMJ. 1994;308(6927):533.

    Article  CAS  Google Scholar 

  12. Andrews PA, Sampson SA. Topical non-steroidal drugs are systemically absorbed and may cause renal disease. Nephrol Dial Transplant. 1999;14(1):187–9.

    Article  CAS  Google Scholar 

  13. Nishtala PS, Chyou TY. Identifying drug combinations associated with acute kidney injury using association rules method. Pharmacoepidemiol Drug Saf. 2020;29(4):467–73.

    Article  CAS  Google Scholar 

  14. Chi T-Y, Zhu H-M, Zhang M. Risk factors associated with nonsteroidal anti-inflammatory drugs (NSAIDs)-induced gastrointestinal bleeding resulting on people over 60 years old in Beijing. Medicine (Baltimore). 2018;97(18):e0665.

    Article  CAS  Google Scholar 

  15. Harvey JA, Chastin SF, Skelton DA. Prevalence of sedentary behavior in older adults: a systematic review. Int J Environ Res Public Health. 2013;10(12):6645–61.

    Article  Google Scholar 

  16. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Annal Intern Med. 2009;150(9):604–12.

    Article  Google Scholar 

  17. Dreischulte T, Morales DR, Bell S, Guthrie B. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin–angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney Int. 2015;88(2):396–403.

    Article  CAS  Google Scholar 

  18. Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1–138.

    Article  Google Scholar 

  19. Schneider V, Lévesque LE, Zhang B, Hutchinson T, Brophy JM. Association of selective and conventional nonsteroidal antinflammatory drugs with acute renal failure: a population-based, nested case-control analysis. Am J Epidemiol. 2006;164(9):881–9.

    Article  Google Scholar 

  20. Griffin MR, Yared A, Ray WA. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol. 2000;151(5):488–96.

    Article  CAS  Google Scholar 

  21. Horl WH. Nonsteroidal anti-inflammatory drugs and the kidney. Pharmaceuticals. 2010;3(7):2291–321.

    Article  Google Scholar 

  22. Chou C-I, Shih C-J, Chen Y-T, Ou S-M, Yang C-Y, Kuo S-C, et al. Adverse effects of oral nonselective and cyclooxygenase-2-selective NSAIDs on hospitalization for acute kidney injury: a nested case–control cohort study. Medicine (Baltimore). 2016;95(9):e2645.

    Article  CAS  Google Scholar 

  23. Solomon DH, Husni ME, Wolski KE, Wisniewski LM, Borer JS, Graham DY, et al. Differences in safety of nonsteroidal antiinflammatory drugs in patients with osteoarthritis and patients with rheumatoid arthritis: a randomized clinical trial. Arthritis Rheumatol. 2018;70(4):537–46.

    Article  CAS  Google Scholar 

  24. Kate RJ, Perez RM, Mazumdar D, Pasupathy KS, Nilakantan V. Prediction and detection models for acute kidney injury in hospitalized older adults. BMC Med Inform Decis Mak. 2016;16(1):39.

    Article  Google Scholar 

  25. Evans J, McGregor E, McMahon AD, McGilchrist MM, Jones MC, White G, et al. Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure. QJM. 1995;88(8):551–7.

    CAS  PubMed  Google Scholar 

  26. Lin TC, Solomon DH, Tedeschi SK, Yoshida K, Kao Yang YH. Comparative risk of cardiovascular outcomes between topical and oral nonselective NSAIDs in Taiwanese patients with rheumatoid arthritis. J Am Heart Assoc. 2017;6(11):e006874.

    Article  Google Scholar 

  27. Makris UE, Kohler MJ, Fraenkel L. Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: a systematic literature review. J Rheumatol. 2010;37(6):1236–43.

    Article  CAS  Google Scholar 

  28. Pham PC, Khaing K, Sievers TM, Pham PM, Miller JM, Pham SV, et al. 2017 update on pain management in patients with chronic kidney disease. Clin Kidney J. 2017;10(5):688–97.

    Article  CAS  Google Scholar 

  29. Persons O. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57(8):1331–46.

    Article  Google Scholar 

  30. Davison SN, Rathwell S, George C, Hussain ST, Grundy K, Dennett L. Analgesic use in patients with advanced chronic kidney disease: a systematic review and meta-analysis. Can J Kidney Health Dis. 2020;7:2054358120910329.

    Article  Google Scholar 

  31. Zhan M, Doerfler RM, Xie D, Chen J, Chen H-Y, Diamantidis CJ, et al. Association of opioids and nonsteroidal anti-inflammatory drugs with outcomes in CKD: findings from the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis. 2020;76(2):184–93.

    Article  CAS  Google Scholar 

  32. Pickering G, Marcoux M, Chapiro S, David L, Rat P, Michel M, et al. An algorithm for neuropathic pain management in older people. Drugs Aging. 2016;33(8):575–83.

    Article  Google Scholar 

  33. Modig S, Elmståhl S. Kidney function and use of nonsteroidal anti-inflammatory drugs among elderly people: a cross-sectional study on potential hazards for an at risk population. Int J Clin Pharm. 2018;40(4):870–7.

    Article  CAS  Google Scholar 

  34. Pilotto A, Franceschi M, Leandro G, Di Mario F. NSAID and aspirin use by the elderly in general practice. Drugs Aging. 2003;20(9):701–10.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the SingHealth Health Services Research Center, the SingHealth Research Office, the Research Efficiency Enhancement Program, and the SingHealth Polyclinics Department of Research Administration for administrative support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cynthia Ciwei Lim.

Ethics declarations

Funding

This research was supported by the SHF-Foundation Research Grant (SHF/HSRHO014/2017).

Conflicts of interest

Cynthia Ciwei Lim, Andrew Teck Wee Ang, Hanis Bte Abdul Kadir, Puay Hoon Lee, Bandy Qiuling Goh, Sudha Harikrishnan, Jia Liang Kwek, Sheryl S.W. Gan, Jason Chon Jun Choo, and Ngiap Chuan Tan have no conflicts of interest that are directly relevant to the content of this article.

Ethics approval

This study was conducted according to the Declaration of Helsinki. Waiver of informed consent for use of de-identified electronic medical record data was approved by the local institutional review board (2018/2567).

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and material

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Code availability

Not applicable.

Authors’ contributions

CCL, ATWA, TNC, PHL, BQG, KJL, and JC contributed to the study conception and design. Material preparation, data collection, and analysis were performed by CCL, HBAK, and SH. The first draft of the manuscript was written by CCL. All authors read and approved the final manuscript.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 136 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lim, C.C., Ang, A.T.W., Kadir, H.B.A. et al. Short-Course Systemic and Topical Non-Steroidal Anti-Inflammatory Drugs: Impact on Adverse Renal Events in Older Adults with Co-Morbid Disease. Drugs Aging 38, 147–156 (2021). https://doi.org/10.1007/s40266-020-00824-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-020-00824-4

Navigation